Test Updates
Clinical Labs of Hawaii provides test updates for educational purposes to physicians, specialists, and the general public.
| Test Update | Date |
|---|---|
Hawaii DOH Medical Advisory: Update #7 - Coronavirus Disease 2019 (COVID-19) Updated information on private laboratory testing for SARS-CoV-2 (COVID-19), including priorities for testing | 2020_03_25 |
SARS-CoV-2 (COVID-19) New Test Update as of Tuesday, March 17, 2020 with Collection Instructions Effective March 10, 2020, Clinical Labs of Hawaii began offering testing for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). | 2020_03_23 |
United Healthcare Insurance March 1, 2020 Billing Update Beginning March 1, 2020, United Healthcare Insurance will require prior authorization/notification for genetic and molecular testing performed in an outpatient setting. | 2020_03_01 |
CLH offers the FilmArray Respiratory Panel from BioFire Diagnostics for the detection of 17 respiratory viruses and 3 bacteria from a single specimen. This panel does NOT test for the SARS-CoV-2 virus. | 2020_02_14 |
Biotin Interference Test Update Biotin administration (especially in high doses) may impact common, immunoassay-based, laboratory tests. | 2020_01_15 |
Human Papillomavirus (HPV) New Methodology and Algorithm CLH/PPPL will be performing Human Papillomavirus (HPV) testing locally on Oahu using the Aptima nucleic acid amplification assay. | 2019_11_11 |
Rapid HIV-1/2 Antigen/Antibody Combo Test Update Clinical Labs of Hawaii is pleased to offer the Rapid Alere Determine™ HIV-1/2 Ag/Ab Combo qualitative immunoassay for the simultaneous detection of HIV-1 p24 antigen and antibodies to HIV-1 and HIV2. | 2019_05_23 |
Chlamydia and Gonorrhea Test Update Test codes for CT-GC testing by Transcription Mediated Amplification (TMA) have been updated. | 2019_05_21 |
Clinical Labs of Hawaii is please to announce the introduction of the QuantiFERON-TB Gold Plus (QFT-Plus) assay, which offers optimized analyses with tuberculosis (TB)-specific antigens that elict both CD4+ and CD8+ T-cell responses. | 2019_02_04 |
Effective January 30, 2019 Clinical Labs of Hawaii will offer in-house testing for N-terminal pro B-type Natriuretic Peptide (NT-proBNP) as a replacement for current BNP testing. | 2019_01_30 |
High Sensitivity Cardiac Troponin T Effective January 30, 2019, Clinical Labs will offer in-house testing for High Sensitivity Cardiac Troponin T (cTnT GEN 5) as a replacement for current Troponin I testing. | 2019_01_30 |
Immunoassay Reference Range Update Effective January 30, 2019, Clinical Labs of Hawaii will be implementing the Roche Diagnostic Cobas® System of immunoassay analyzers. Please read bulletin for important reference range updates. | 2019_01_30 |